|
Using a direct service model to provide workplace prevention, care, support and treatment
| Categories | | Company: | Industry: | Country: | Disease: | Last Updated: | | AngloGold | Metals & Mining | South Africa | HIV/AIDS | October 2003 | Key Questions | • How can AngloGold help ensure comprehensive treatment for employees after they elect to take illhealth retirement?
• How can AngloGold continue to contribute to local communities to ensure that improvements to medical infrastructure are sustainable?
• How can smaller employers provide a subset of this comprehensive programme at an affordable cost?
|
|
Download the full AngloGold HIV/AIDS South Africa Case Study or preview the first page below:
Case Study Executive Summary
| Overview | AngloGold is a large international gold mining company.- The company has 20 operations in Africa, North and South America and Australia. AngloGold produced 5.9 million ounces of gold in 2002.
- At the end of 2002, the company employed approximately 53,000 people worldwide. The majority of AngloGold’s workforce is in South Africa where they have 44,800 workers, including 6,600 contractors.
- Anglo American has a 51.5% stake in AngloGold.
- AngloGold generated US$ 1.8 billion in sales and US$ 332 million in net income in 2002.
|
 | | Condoms can aid prevention.
| |
Business
Case | Due to a combination of economic factors and an obligation to its workers, AngloGold established a comprehensive HIV/AIDS programme.- Based on anonymous company prevalence surveys, national antenatal surveillance data and other regional data for comparable populations, AngloGold estimated the 2002 HIV prevalence to be 30% in its South African workforce.
- AngloGold worked in conjunction with two actuarial companies that provided different estimates as to when HIV/AIDS expenses would peak. In 2009, HIV/AIDS expenses are estimated to range from 8% to 17% of payroll depending on the actuarial model used. This variability in projections has led to the decision to develop a company-specific model to more accurately assess the impact of HIV/AIDS.
- AngloGold’s 2003 budget for workplace and community HIV/AIDS intervention programmes is US$ 2.6 million, which corresponds to US$ 58 per employee per year.
- AngloGold budgeted US$ 244 per patient per month to provide employees with highly active anti-retroviral therapy (HAART) during a trial running from November 2002 to March 2003 and rollout till December 2003 for a projected uptake of 820 patients. Falling drug and laboratory prices mean that this estimate can be revised to $140 per patient per month at the time of writing
|
| Programme Description | AngloGold uses a direct service model to provide workplace prevention, Voluntary Counselling and Testing (VCT), care, support and treatment programmes.- AngloGold revised its HIV-specific policy with its five labour organizations establishing a new partnership in July 2002.
- Workplace prevention programmes have been improving since 1985, focusing on awareness events, training, peer education, condom distribution and syndromic management of Sexually Transmitted Infections (STIs).
- AngloGold uses industry partnerships to reduce the risk of HIV/AIDS transmission in neighbouring communities by targeting commercial sex workers to receive STI treatment, condoms, and peer education.
- A VCT programme is available free of charge to all employees and partners. AngloGold is also working with local health departments to make these VCT facilities available to communities.
- AngloGold extended its comprehensive wellness management programme for HIV infected individuals to include HAART for employees in November 2002.
- AngloGold provides home-based care for approximately 45% of its ill-health retirees. This service is provided through industry, public, and NGO partnerships in high labour sending rural and peri mine communities.
|
| Programme Evaluation | AngloGold's HIV/AIDS programme has a workplace programme review committee, a clinical HIV working group and a joint management-labour committee to implement, monitor and review the programme. This is complemented through research conducted by Aurum Health Research and both an internal and proposed external audit process.
In the next year, AngloGold will focus on improving programme performance in the following five quantifiable areas: (1) doubling VCT uptake; (2) increasing HAART enrolment by 150%; (3) renewed prevention education efforts to pre-empt treatment complacence; (4) explore means to assist local health services to provide enhanced treatment; (5) evaluating behaviour change communication methods to ensure they are appropriate and effective.
. |
| Documents | AngloGold HIV/AIDS South Africa Case Study (PDF format; 9 pages; 113k)
AngloGold and Labour HIV/AIDS Agreement (Policy) (PDF format; 11 pages; 53k)
AngloGold HIV Counseling and Testing Procedure (PDF format; 11 pages; 53k)
AngloGold Wellness Clinic Protocol (PDF format; 18 pages; 88k)
AngloGold HIV Powerpoint Update (December 2002) (PDF format; 27 pages; 655k)
AngloGold HAART Protocol (June 2003) (PDF format; 39 pages; 338k)
AngloGold HIV/AIDS Interventions Update (September 2003) (PDF format; 6 pages; 99k)
|
Case studies are written by Peter DeYoung and developed in collaboration with the featured company. Supporting Documents are provided 'as is' by the contributing organization. GHI member companies and partners, the World Economic Forum and the contributing company do not necessarily subscribe to every view expressed herein. Although the GHI makes reasonable efforts to ensure the accuracy of the statements, this report should not be viewed as an external audit of the programme described. Please contact the GHI for any questions, feedback or submissions related to this case study.
|